Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...

Advanz won a temporary reprieve in September after the General Court of the European Union ordered a suspension of the EC's ...

Trump has nominated Dr Jay Bhattacharya, a 56-year-old physician and health economist at Stanford University School of ...

Significant breakthroughs in CNS biology, coupled with innovative neuroscience technologies and a more supportive regulatory ...

Returning to Boston in March, the 8th Gene Therapy Development Summit, formerly known as the Gene Therapy for Rare Disorders ...

“It’s a really exciting time, not just for NWEH, but also for the future of clinical trials in the UK. If successful, this ...

The European Commission has cleared use of CDK4/6 inhibitor Kisqali (ribociclib) to reduce the risk of recurrence in patients with stage 2 or 3, HR-positive/HER2-negative early breast cancer, based on ...

In the ever-evolving cell therapy landscape, the challenge of potency assay development remains critical. At the 4th Cell Therapy Potency Assay Summit, we will unite analytical development, quality ...

That increased convenience will have to be accompanied by weight loss that is at least as effective as its rivals, and Amgen ...

Celebrating 10 years as the definitive platform for the NK community, the flagship Innate Killer Summit will unite ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in ...